{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:39:10Z","timestamp":1742391550516,"version":"3.30.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,7]]},"DOI":"10.7759\/cureus.75274","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:52:06Z","timestamp":1733586726000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Chronic Lymphocytic Leukemia Transforming Into Waldenstr\u00f6m Macroglobulinemia During Ibrutinib Therapy"],"prefix":"10.7759","author":[{"given":"Kazi","family":"Samsuddoha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvester","family":"Homsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Preet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamrun","family":"Naher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.144","article-title":"Diagnosis and management of Waldenstrom's macroglobulinemia","volume":"23","author":"Dimopoulos MA","year":"2005","unstructured":"Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol. 2005, 23:1564-77. 10.1200\/JCO.2005.03.144","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:e538-e548.","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon SP","year":"2012","unstructured":"Treon SP, Xu L, Yang G, et al.. MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia. N Engl J Med. 2012, 367:826-33. 10.1056\/NEJMoa1200710","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni M","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, et al.. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood. 2013, 121:2522-8. 10.1182\/blood-2012-09-457101","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter ZR","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, et al.. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014, 123:1637-46. 10.1182\/blood-2013-09-525808","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon SP","year":"2020","unstructured":"Treon SP, Xu L, Guerrera ML, et al.. Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies. J Clin Oncol. 2020, 38:1198-208. 10.1200\/JCO.19.02314","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","article-title":"Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course","volume":"116","author":"Mansoor A","year":"2001","unstructured":"Mansoor A, Medeiros LJ, Weber DM, et al.. Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001, 116:543-9. 10.1309\/6U88-357U-UKJ5-YPT3","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17028","article-title":"6q deletion in Waldenstr\u00f6m macroglobulinaemia negatively affects time to transformation and survival","volume":"192","author":"Garc\u00eda-Sanz R","year":"2021","unstructured":"Garc\u00eda-Sanz R, Dogliotti I, Zaccaria GM, et al.. 6q deletion in Waldenstr\u00f6m macroglobulinaemia negatively affects time to transformation and survival. Br J Haematol. 2021, 192:843-52. 10.1111\/bjh.17028","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garc\u00eda-Sanz R","year":"2001","unstructured":"Garc\u00eda-Sanz R, Montoto S, Torrequebrada A, et al.. Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol. 2001, 115:575-82. 10.1046\/j.1365-2141.2001.03144.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.03.008","article-title":"Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia","volume":"67","author":"Vitolo U","year":"2008","unstructured":"Vitolo U, Ferreri AJ, Montoto S. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia. Crit Rev Oncol Hematol. 2008, 67:172-85. 10.1016\/j.critrevonc.2008.03.008","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280443-a-rare-case-of-chronic-lymphocytic-leukemia-transforming-into-waldenstrm-macroglobulinemia-during-ibrutinib-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:52:07Z","timestamp":1733586727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280443-a-rare-case-of-chronic-lymphocytic-leukemia-transforming-into-waldenstrm-macroglobulinemia-during-ibrutinib-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.75274","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,7]]}}}